Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting, stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i) : subanalysis of the ALOHA2 study, drug-use surveillance in Japan

• Shoko Tsukube

• Takashi Kadowaki

• Masato Odawara

収録刊行物

• Diabetology international / Japan Diabetes Society

  Diabetology international / Japan Diabetes Society 7 (3), 299–307-, 2016

  Tokyo : Springer Japan Production Department

キーワード

• Basal supported oral therapy
• Dipeptidyl peptidase-4 inhibitors
• Insulin glargine
• Real-life observational study
• Type 2 diabetes

詳細情報

• CRID: 1524232505163373184
• NII論文ID: 40020934130
• NII書誌ID: AA12503387
• ISSN: 21901678
• NDL書誌ID: 027601467
• Web Site: https://ndlsearch.ndl.go.jp/books/R000000004-I027601467
• 本文言語コード: en
• NDL 雑誌分類:
  • ZS21(科学技術--医学--内科学)
• データソース種別:
  • NDL
  • CiNii Articles